Why You Molecular Marker Testing On Suspicious thyroid biopsies Can Save You a Surgery.
Comments: No patient should go to surgery with an indeterminate result on a thyroid biopsy in 2017. The use of marker testing on needle biopsy needle washout samples and even on the slides after the biopsy ( microdissection of nuclei acids ) can reduce the surgeries in benign nodules by 85%. Do you really want to allow you local surgeon to take you in the hospital,operate, and during your recovery tell you it is benign when you could have known that by having marker testing. Get another opinion bey you submit to surgery. Interpace has a unique system of markers and a reflex classifier on needle washout and by microdissection of prior needle biopsy slides. This is one of the best ways to save yourself a surgery. They have 85% reduction in surgery in benign nodules when the biopsy gave indeterminate results and their results were benign.
RosettaGX has a system to do markers on slides as well.
Richard Guttler MD,FACE,ECNU
ROLE OF MOLECULAR MARKERS IN THYROID NODULE MANAGEMENT: THEN AND NOW.
“The evolution of molecular tests for thyroid nodules followed the discovery of various diagnostic and prognostic molecular markers of thyroid cancer that can be applied to thyroid FNA samples to inform more individualized management of these patients.”